CPSC recall 25223 · Apr 10, 2025
Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging
Product
Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs
Hazard
The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
What to do
Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Recall details
- Description
- This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
- Units
- About 14,250
- Incidents and injuries
- None reported
- Sold at
- HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.
- Company
- Kramer Laboratories, of Bridgewater, New Jersey (a subsidiary of Arcadia Consumer Healthcare, of Bridgewater, New Jersey)
- Manufactured in
- India
- Consumer contact
- Kramer Laboratories at 800-824-4894 Monday through Friday 8 a.m. to 5 p.m. ET, e-mail at [email protected], or online at https://safetussin.com/recall for more information.
Source: U.S. Consumer Product Safety Commission (CPSC) notice.
Copied from the agency record without changes. Data as of Oct 14, 2026, 1:15 AM EDT. The agency notice is the final word.
Check something else